Tamsulosin CAS 106133-20-4

Product Description:

Product Name: Tamsulosin CAS NO: 106133-20-4

Synonyms:

5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;

(R)-(-)-5-[2-(2-(2-ethoxyphenoxy)ethylamino)propyl]-2-methoxybenzenesulfonamide;

Flomax;

Chemical & Physical Properties:

Appearance: White crystals

Assay :≥99.00%

Density: 1.191 g/cm3

Boiling Point: 595.5℃ at 760 mmHg

Melting Point: 226-228℃

Flash Point: 313.9℃

Refractive Index: 1.553

Vapor Pressure: 3.79E-14mmHg at 25℃

Safety Information:

HS Code: 2935009090

Tamsulosin (rINN) (trade name Flomax) is an α1a adrenergic receptor antagonist used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and was first marketed in 1996 as Flomax, and also under the name Omnic.

Tamsulosin is used in the treatment of difficult urination, a common symptom of enlarged prostate. Tamsulosin, and other medications in the class called alpha blockers, work by relaxing bladder neck muscles and muscle fibers in the prostate itself and make it easier to urinate.

The U.S. patent for Flomax expired in October 2009. The U.S. Food and Drug Administration (FDA) approved generic Flomax in March 2010.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.